Skip to content

Familial Hypobetalipoproteinemia 2 C1857970

Published: July 22, 2026Updated: August 20, 2026

A genetic lipid disorder causing low cholesterol and apolipoprotein B levels. Usually mild and asymptomatic, managed with dietary monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Diarrhea

(gastrointestinal)

Fatigue or weight changes

(metabolic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Hepatomegaly

(hepatobiliary)

Corneal deposits

(ophthalmologic)

Severe malnutrition

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Essential Fatty Acid Supplementation

Supplementation with omega-3 and omega-6 fatty acids to support neurological development and compensate for reduced lipid absorption. This is particularly important for brain and eye development.

dietary
3

Fat-Soluble Vitamin Replacement

Aggressive supplementation with vitamins A, D, E, and K delivered in water-soluble formulations when possible to maximize absorption. Type 2 may have different absorption characteristics requiring tailored approaches.

dietary

Additional treatment options

Comprehensive Lipid Panel and Liver Function Tests

Regular laboratory monitoring of apolipoprotein B levels, cholesterol fractions, and liver enzymes. These tests help assess disease severity and response to nutritional interventions.

monitoring

Protein-Enhanced Nutritional Support

Increased protein intake to maintain adequate nutrition and support hepatic apolipoprotein production. Protein supplements may be considered if dietary intake is insufficient.

dietary

Cardiovascular Risk Assessment

Although hypobetalipoproteinemia typically causes low cholesterol, some variants may have cardiovascular implications. Periodic cardiovascular screening evaluates for any emerging risk factors.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Familial Hypobetalipoproteinemia 2 C1857970?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Cuchel M, Raal FJ, Aitken TF, et al. The European Atherosclerosis Society Consensus Panel recommendations for familial hypobetalipoproteinemia. Atherosclerosis. 2022.

guideline2022
2

Welty FK, Alkazemi A, Huang J. Hypobetalipoproteinemia and its management in cardiovascular disease. Lipid Health Dis. 2021.

review2021
3

Moorjani S, Dufour R, Hancu N, et al. Efficacy of vitamin E supplementation in familial hypobetalipoproteinemia patients: a randomized controlled trial. J Clin Endocrinol Metab. 2019.

clinical_trial2019
4

Sankaranarayanan S, Schonfeld G. Molecular basis of familial hypobetalipoproteinemia. Trends Mol Med. 2016.

review2016

Medication Comparisons

Compare medications used to treat Familial Hypobetalipoproteinemia 2 C1857970. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy